201 related articles for article (PubMed ID: 1553370)
21. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
[TBL] [Abstract][Full Text] [Related]
22. The cholecystokinin antagonist L-364,718 inhibits the action of cholecystokinin but not bombesin on rat pancreatic secretion in vivo.
Anderson L; Dockray GJ
Eur J Pharmacol; 1988 Feb; 146(2-3):307-11. PubMed ID: 3371402
[TBL] [Abstract][Full Text] [Related]
23. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
Zucker KA; Adrian TE; Bilchik AJ; Modlin IM
Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
[TBL] [Abstract][Full Text] [Related]
24. Synthetic neuromedin C stimulates exocrine pancreatic secretion in dogs and rats.
Hosotani R; Inoue K; Kogire M; Suzuki T; Otsuki M; Rayford PL; Yajima H; Tobe T
Pancreas; 1987; 2(4):414-21. PubMed ID: 2442749
[TBL] [Abstract][Full Text] [Related]
25. Role of cholecystokinin in the inhibition of gastric acid secretion in dogs.
Konturek SJ; Bilski J; Tasler J; Cieszkowski M
J Physiol; 1992; 451():477-89. PubMed ID: 1403819
[TBL] [Abstract][Full Text] [Related]
26. Distinct receptors for cholecystokinin and gastrin on muscle cells of stomach and gallbladder.
Grider JR; Makhlouf GM
Am J Physiol; 1990 Aug; 259(2 Pt 1):G184-90. PubMed ID: 2382717
[TBL] [Abstract][Full Text] [Related]
27. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.
Lotti VJ; Chang RS
Eur J Pharmacol; 1989 Mar; 162(2):273-80. PubMed ID: 2721567
[TBL] [Abstract][Full Text] [Related]
28. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.
Niederau M; Niederau C; Strohmeyer G; Grendell JH
Am J Physiol; 1989 Jan; 256(1 Pt 1):G150-7. PubMed ID: 2463767
[TBL] [Abstract][Full Text] [Related]
29. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z
J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728
[TBL] [Abstract][Full Text] [Related]
30. The role of CCK and its analogues in the organogenesis of the fetal rat pancreas.
Feurle GE; Hamscher G; Firat AE
Pancreas; 1995 Apr; 10(3):281-6. PubMed ID: 7624305
[TBL] [Abstract][Full Text] [Related]
31. The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.
Hayward NJ; Harding M; Lloyd SA; McKnight AT; Hughes J; Woodruff GN
Br J Pharmacol; 1991 Dec; 104(4):973-7. PubMed ID: 1687371
[TBL] [Abstract][Full Text] [Related]
32. Effect of a new CCK-receptor antagonist, CR 1409, on pancreatic growth induced by caerulein, CCK-8, bombesin and gastrin-releasing peptide in the rat.
Hajri A; Aprahamian M; Damgé C
Digestion; 1989; 43(1-2):66-72. PubMed ID: 2806757
[TBL] [Abstract][Full Text] [Related]
33. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
34. Evidence for the direct action of gastrin-releasing peptide (GRP) on amylase secretion from rat pancreatic acini: an assessment using a perifusion system.
Shinozaki H; Funakoshi A
Jpn J Physiol; 1988; 38(3):299-307. PubMed ID: 2460654
[TBL] [Abstract][Full Text] [Related]
35. The effects of antagonists of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Jun; 42(2):195-209. PubMed ID: 1664265
[TBL] [Abstract][Full Text] [Related]
36. The mechanism of action of gastrin releasing peptide (GRP) in stimulating avian gastric acid secretion.
Campbell BJ; Garner A; Dockray GJ; Hughes J; Dimaline R
Regul Pept; 1994 Jan; 49(3):249-55. PubMed ID: 8140277
[TBL] [Abstract][Full Text] [Related]
37. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
Menozzi D; Gardner JD; Jensen RT; Maton PN
Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
[TBL] [Abstract][Full Text] [Related]
38. Role of cholecystokinin in the intestinal fat- and acid-induced inhibition of gastric secretion.
Konturek SJ; Bilski J; Cieszkowski M
Regul Pept; 1992 Nov; 42(1-2):97-109. PubMed ID: 1475410
[TBL] [Abstract][Full Text] [Related]
39. Different effects of CCK antagonists on gastric-acid response to CCK and pentagastrin.
Corwin RL; Smith GP
Peptides; 1993; 14(2):253-7. PubMed ID: 8483804
[TBL] [Abstract][Full Text] [Related]
40. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
Boyle SJ; Tang KW; Woodruff GN; McKnight AT
Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
